Ten-year Overview

ten-year overview (in € million, unless otherwise stated)
	1999	2000	2001	2002	2003¹	2004	2005	2006²	2007²	2008²
Sales	3,638	4,116	4,542	4,742	4,435	4,546	4,776	5,120	5,507	5,971
Change against prior year in %	8.7	13.1	10.3	4.4	–1.3	2.5	5.1	7.2	7.6	8.4
Consumer⁷	3,010	3,448	3,870	4,049	3,739	3,840	4,041	4,327	4,661	5,125
tesa	628	668	672	693	696	706	735	793	846	846
Europe	2,687	2,855	3,183	3,410	3,329	3,388	3,498	3,717	3,909	4,090
Americas	630	832	903	819	638	635	687	738	782	832
Africa/Asia/Australia	321	429	456	513	468	523	591	665	816	1,049
EBITDA	468	538	620	633	614	656	693	660	738	911
Operating result (EBIT)	339	389	466	472	455	483	531	477	616	797
Profit before tax	323	382	468	478	491	492	535	851	644	822
Profit after tax	175	226	285	290	301	302	335	668	442	567
Return on sales (after tax) in %	4.8	5.5	6.3	6.1	6.4	6.6	7.0	13.0	8.0	9.5
Earnings per share in €	0.68	0.87	1.11	1.12	1.17	1.29	1.45	2.93	1.93	2.48
Total dividend equity holders	60	84	109	118	121	121	129	136	159	204
Dividend per share in €	0.24	0.33	0.43	0.47	0.53	0.53	0.57	0.60	0.70	0.90
Beiersdorf share year-end closing price⁶	22.22	37.17	42.5	35.37	32.07	28.53	34.64	49.12	53.00	42.00
Market capitalization as of Dec. 31⁷	5,599	9,366	10,710	8,912	8,081	7,190	8,736	12,378	13,356	10,584
Cost of materials	995	1,112	1,196	1,205	1,149	1,113	1,147	1,229	1,285	1,453
Personnel expenses	713	786	817	863	808	804	840	889	889	922
Research and development expenses	79	88	92	93	97	101	109	118	127	149
In % of sales	2.2	2.1	2.0	2.0	2.2	2.2	2.3	2.3	2.3	2.5
Employees as of Dec. 31	16,065	16,590	17,749	18,183	18,664	16,492	16,769	17,172	21,101	21,766
Intangible assets	56	118	138	128	94	58	34	30	357	389
Property, plant, and equipment	782	808	871	917	876	887	882	740	699	727
Non-current financial assets	26	24	18	22	94	93	5	8	7	11
Inventories	515	595	695	677	629	558	536	548	598	634
Receivables and other assets⁴	701	804	811	832	789	815	967	940	1,123	2,085
Cash and cash equivalents	622	632	714	722	828	290	483	1,230	1,117	613
Equity	1,289	1,458	1,636	1,727	1,831	1,033	1,293	1,790	2,070	2,460
Liabilities	1,413	1,523	1,611	1,571	1,479	1,668	1,614	1,706	1,831	1,999
Provisions	690	752	761	808	790	776	752	809	781	729
Trade payables	322	356	337	293	293	308	369	485	573	690
Other financial liabilities	174	180	237	191	157	300	197	137	220	246
Other liabilities⁵	227	235	276	279	239	284	296	275	257	334
Total equity and liabilities	2,702	2,981	3,247	3,298	3,310	2,701	2,907	3,496	3,901	4,459

Restated to reflect the new reporting structure (BSN medical at equity).

Figures include special factors. For details please refer to the notes.

Excluding changes in carrying amounts resulting from measurement using the equity method.

⁴

Including non-current assets and disposal groups held for sale.

⁵

Including liabilities held for sale.

⁶

Figures 1999 to 2005 adjusted to the number of shares after the share split.

⁷

Consumer figures 1999 to 2002 include sales of the former segments cosmed and medical.